P&K Skin Research Center Co.,Ltd. Q3 profit from the main business KRW 1.2 billion, up 167.3% from a year earlier
AI summary · Not investment advice
In Q3, the company sold KRW 6.8 billion of goods and earned KRW 1.2 billion from its main business, up 167.3% from a year earlier and down 20.0% from the prior quarter.
Operating profit · 3 months
KRW 1.2 billion
Key facts
- Revenue (3 months)
- KRW 6.8 billion
- Net income (3 months)
- KRW 556.5 million
- Period
- Q3 (cumulative 2026.01.01 ~ 2026.09.30)
- Revenue (prior-year 3 months)
- KRW 5.1 billion
- Revenue (year to date)
- KRW 19.6 billion
- Operating profit (prior-year 3 months)
- KRW 451.8 million
- Operating profit (year to date)
- KRW 3.7 billion
- Net income (prior-year 3 months)
- KRW 1.6 billion
- Net income (year to date)
- KRW 3.5 billion
Commentary
AI commentary · Not investment advice
What happened
PNK Skin Clinical Research Center reported its consolidated results for the third quarter of 2026 in a quarterly report.
In the company's terms
Sales for the latest 3 months were KRW 6.76 billion. That is up 33.8% from the same 3 months a year earlier and up 2.5% from the previous quarter. Cumulative sales this year are KRW 19.59 billion.
What changes for shareholders
Operating profit (profit from the core business) for the latest 3 months was KRW 1.21 billion. That is up 167.3% from a year earlier and down 20.0% from the previous quarter. Cumulative operating profit this year is KRW 3.68 billion.
Net income (the final profit after taxes and other costs) for the latest 3 months was KRW 556.5 million. That is down 64.6% from a year earlier and down 63.1% from the previous quarter. Cumulative net income this year is KRW 3.52 billion.
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
P